Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown that the commonly used high-cholesterol drug simvastatin cannot slow disability progression.
Sep 24, 2024
0
0
For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes, according to a study published online Sept. 18 in JAMA Neurology to coincide with the annual meeting of the ...
Sep 23, 2024
0
0
New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, ...
Sep 17, 2024
0
5
A study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new insights that could reshape treatment approaches for diverse populations affected by the disease. The research, ...
Sep 17, 2024
0
6
A team of scientists from The New York Stem Cell Foundation (NYSCF) Research Institute and Case Western Reserve University has created the largest reported collection of stem cell models from multiple sclerosis (MS) patients ...
Aug 26, 2024
0
9
New research, led by the University of Southampton and University Hospital Southampton, shows that inflammation outside the brain, such as that caused by common infections such as colds and urine infections, is linked to ...
Jul 23, 2024
0
11
Researchers at Durham University, UK and Isfahan University of Medical Sciences, Iran have developed an innovative approach to diagnosing multiple sclerosis using advanced eye imaging techniques.
Jul 17, 2024
0
1
The role that Epstein-Barr virus (EBV) plays in the development of multiple sclerosis (MS) may be caused by a higher level of cross-reactivity, where the body's immune system binds to the wrong target, than previously thought.
Jun 6, 2024
0
63
A team of experts in multiple sclerosis (MS) research recommends a structured approach to the study of mechanisms of exercise training for improving outcomes for multiple sclerosis (MS).
May 23, 2024
0
0
B cells can control responses of myeloid cells through the release of particular cytokines (small proteins that control the growth and activity of cells in the immune system), disproving the previous consensus that T cells ...
May 6, 2024
0
7
